SMALL DELETION AND INSERTION MUTATIONS INDUCED BY THE TOPOISOMERASE-II INHIBITOR TENIPOSIDE IN CHO CELLS AND COMPARISON WITH SITES OF DRUG-STIMULATED DNA CLEAVAGE INVITRO

被引:57
作者
HAN, YH
AUSTIN, MJF
POMMIER, Y
POVIRK, LF
机构
[1] VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PHARMACOL & TOXICOL,RICHMOND,VA 23298
[2] NCI,MOLEC PHARMACOL LAB,BETHESDA,MD 20892
关键词
APRT GENE; VM-26; ILLEGITIMATE RECOMBINATION; CLEAVABLE COMPLEX; SEQUENCE SPECIFICITY;
D O I
10.1006/jmbi.1993.1007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Sixty-five teniposide-induced mutations at the hemizygous aprt locus of CHO D422 cells were analyzed by polymerase chain reaction and DNA sequencing. Most (63%) of the mutations were deletions, duplications and insertions of various sizes, with the majority being less than 20 base-pairs. The remaining mutations were base substitutions, the majority of which were transversions. A significant correspondence was found between the teniposide-induced small deletion/duplication mutations and sites of teniposide-stimulated DNA strand cleavage by topoisomerase II in vitro. In particular, sequences which were deleted in one or more of the mutants showed a much higher incidence of strong cleavage sites than sequences not involved in deletions. However, the exact positioning of the cleavage sites with respect to the deletion termini was variable. The data did not suggest any unified model to account for all the mutations, but most of the deletions and duplications could be accounted for by one of three mechanisms: (1) double-strand break repair nonhomologous end-joining; (2) replication slippage/misalignment; and (3) addition or deletion of a few nucleotides at free 3' ends left by topoisomerase II, as previously suggested for similar mutations in phage T4. There was no evidence that topoisomerase II subunit exchange was a significant mechanism of mutagenesis in this system. © 1993 Academic Press Limited.
引用
收藏
页码:52 / 66
页数:15
相关论文
共 35 条
[1]   IMPLICATION OF PRIOR TREATMENT WITH DRUG-COMBINATIONS INCLUDING INHIBITORS OF TOPOISOMERASE-II IN THERAPY-RELATED MONOCYTIC LEUKEMIA WITH A 9-11 TRANSLOCATION [J].
ALBAIN, KS ;
LEBEAU, MM ;
ULLIRSCH, R ;
SCHUMACHER, H .
GENES CHROMOSOMES & CANCER, 1990, 2 (01) :53-58
[2]  
AUSTIN MJF, 1992, IN PRESS CANCER GENE
[3]   ILLEGITIMATE RECOMBINATION MEDIATED BY CALF THYMUS DNA TOPOISOMERASE-II INVITRO [J].
BAE, YS ;
KAWASAKI, I ;
IKEDA, H ;
LIU, LF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (07) :2076-2080
[4]   ETOPOSIDE (VP-16-213)-INDUCED GENE ALTERATIONS - POTENTIAL CONTRIBUTION TO CELL-DEATH [J].
BERGER, NA ;
CHATTERJEE, S ;
SCHMOTZER, JA ;
HELMS, SR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (19) :8740-8743
[5]   HIGH-FREQUENCY NONRANDOM MUTATIONAL EVENT AT THE ADENINE PHOSPHORIBOSYLTRANSFERASE (APRT) LOCUS OF SIB-SELECTED CHO VARIANTS HETEROZYGOUS FOR APRT [J].
BRADLEY, WEC ;
LETOVANEC, D .
SOMATIC CELL GENETICS, 1982, 8 (01) :51-66
[6]   LOCAL SEQUENCE REQUIREMENTS FOR DNA CLEAVAGE BY MAMMALIAN TOPOISOMERASE-II IN THE PRESENCE OF DOXORUBICIN [J].
CAPRANICO, G ;
KOHN, KW ;
POMMIER, Y .
NUCLEIC ACIDS RESEARCH, 1990, 18 (22) :6611-6619
[7]   NUCLEOSOME POSITIONING AS A CRITICAL DETERMINANT FOR THE DNA CLEAVAGE SITES OF MAMMALIAN DNA TOPOISOMERASE-II IN RECONSTITUTED SIMIAN VIRUS-40 CHROMATIN [J].
CAPRANICO, G ;
JAXEL, C ;
ROBERGE, M ;
KOHN, KW ;
POMMIER, Y .
NUCLEIC ACIDS RESEARCH, 1990, 18 (15) :4553-4559
[8]   THE CHINESE-HAMSTER APRT GENE AS A MUTATIONAL TARGET - ITS SEQUENCE AND AN ANALYSIS OF DIRECT AND INVERTED REPEATS [J].
DEBOER, JG ;
DROBETSKY, EA ;
GROSOVSKY, AJ ;
MAZUR, M ;
GLICKMAN, BW .
MUTATION RESEARCH, 1989, 226 (04) :239-244
[9]  
DEJONG PJ, 1988, P NATL ACAD SCI USA, V85, P3499
[10]   MUTAGENICITY AND CLASTOGENICITY OF TENIPOSIDE (VM-26) IN L5178Y TK+/--3.7.2C MOUSE LYMPHOMA-CELLS [J].
DEMARINI, DM ;
BROCK, KH ;
DOERR, CL ;
MOORE, MM .
MUTATION RESEARCH, 1987, 187 (03) :141-149